Pharma is on the Competition Bureau's radar

Andrew Skodyn was quoted in this article in the June/July Issue of Canadian Lawyer InHouse, which first appeared on canadianlawyermag.com/inhouse.

"The Competition Bureau is honing in on the pharmaceutical sector, amid concern about alleged market distortions caused by legal settlements and industry practices.

At a conference held last November in Delhi, India, the bureau submitted a paper highlighting the huge significance of the Canadian health care system to the national economy and to residents' well-being..."